Bristol-Myers Squibb to Announce Results for Fourth Quarter 2019 on February 6, 2020
NEW YORK--(BUSINESS WIRE)--Dec 19, 2019--
Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter of 2019 on Thursday, February 6, 2020. During a conference call at 8:30 a.m. ET on February 6, 2020, company executives will review financial information and will address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 888-204-4368 or international 786-789-4797, confirmation code: 5605395. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 11:45 a.m. ET on February 6 through 11:45 a.m. ET on February 20, 2020. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 5605395.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191219005069/en/
Tim Power, 609-252-7509,email@example.com
Nina Goworek, 908-673-9711,firstname.lastname@example.org
KEYWORD: NEW YORK UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH ONCOLOGY
SOURCE: Bristol-Myers Squibb Company
Copyright Business Wire 2019.
PUB: 12/19/2019 06:59 AM/DISC: 12/19/2019 06:58 AM